DR. REDDYS LABORATORIES LIMITED vs FAST CURE PHARMA AND ANR.
$~3
* IN THE HIGH COURT OF DELHI AT NEW DELHI
+ C.O. (COMM.IPD-TM) 8/2023
DR. REDDYS LABORATORIES LIMITED ….. Petitioner
Through: Mr. Ranjan Narula, Mr. Shashi P. Ojha, Ms. Aishani Singh & Ms. Shivangi Kohli, Advs.
versus
FAST CURE PHARMA AND ANR. ….. Respondents
Through: Mr. Harish Vaidyanathan Shankar, CGSC, Mr. Srish Kumar Mishra, Mr. Alexander Mathai Paikaday, Mr. M.Sriram & Mr. Krishnan V., Advs. for R-2.
CORAM:
HON’BLE MR. JUSTICE C. HARI SHANKAR
J U D G M E N T (O R A L)
% 12.10.2023
1. This petition under Section 57 of the Trade Marks Act, 1999 seeks rectification of the register of trademarks by removal, therefrom, of the mark RAZOFAST, registered in favour of Respondent 1 on 23 December 2018 vide Certificate No. 2058491 w.e.f. 25 June 2018.
2. Mr. Ranjan Narula, learned counsel for the petitioner points out that, even as on 25 June 2018 when Respondent 1 had applied for registration of the RAZOFAST wordmark as a trademark, the petitioner was already the proprietor of a registration for the mark RAZO, granted on 23 May 2018 vide certificate no. 1868927. This Court has, vide judgment and decree dated 16 August 2023, passed in CS (COMM.) 436/2021 between the plaintiff and the defendant, already held that the mark RAZOFAST of Respondent 1 infringes the petitioners registered mark RAZO, as it copies and incorporates the entire registered RAZO trademark of the plaintiff and is deceptively similar thereto. That judgment remains undisturbed till date.
3. As such, as the impugned mark is deceptively similar to the mark RAZO of the petitioner, registered prior in point of time, the very Application No. 3869298 filed by Respondent 1 on 25 June 2018, seeking registration of the impugned mark RAZOFAST, in class 5, which was the same class in which the mark RAZO stood registered in favour of the plaintiff on 23 May 2018 w.e.f. 24 May 2012, could not have been granted.
4. The impugned mark RAZOFAST is deceptively similar to the petitioners mark RAZO, registered prior in point of time, registered prior to the filing of the application for registration by Respondent 1 for the mark RAZOFAST. Both the marks are used for the pharmaceutical compound Rabeprazole. In view of these facts, this Court has already held, in its judgment dated 16 August 2023 in CS (COMM.) 436/2021, that the use of the mark RAZOFAST by the defendant is likely to lead to confusion in the market. All considerations, envisaged by Section 11(1)(b) of the Trademarks Act, which would disentitle the application of Respondent 1 for registration of mark RAZOFAST even from consideration, stand satisfied in the present case.
5. Despite notice, Respondent 1 has not turned up to contest the present petition.
6. The registration of the mark RAZOFAST in favour of Respondent 1 vide registration certificate no. 2058491 dated 23 December 2018 is declared illegal. It is, accordingly, cancelled. The Registrar is, therefore, directed to rectify the register of trademarks by removal, therefrom, of the mark RAZOFAST as registered in favour of Respondent 1 vide certificate no. 2058491 dated 23 December 2018 w.e.f. 25 June 2018.
7. The petition is, accordingly, allowed.
C. HARI SHANKAR, J.
OCTOBER 12, 2023
al
Click here to check corrigendum, if any
C.O. (COMM.IPD-TM) 8/2023 Page 1 of 3